Target intelligence / Profile preview

high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20)

Target
HMGN1P20
Molecular classification
Pseudogene, Processed pseudogene, Non-coding RNA
01

Overview

high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20) is a human pseudogene with sequence similarity to the functional HMGN1 gene, which encodes a DNA-binding protein involved in chromatin structure and gene regulation. Pseudogenes are generally non-protein coding due to mutations and genomic rearrangements, but some can act as regulatory non-coding RNAs. No evidence indicates protein translation or direct biological function or disease association for HMGN1P20. The gene is annotated in genomic databases, but minimal research characterizes its expression, function, or involvement in pathology. HMGN1P20 is best classified as a processed pseudogene from the HMGN1 family. It is not recognized as a therapeutic target, lacks clear biological and disease associations, and is primarily annotated for its genomic sequence similarity. There are significant gaps and limitations in available information.

Other names
NCBI Gene 100874459
02

Biological functions

No confirmed biological functions for HMGN1P20 specifically.Other HMGA/HMGN pseudogenes are known to regulate gene expression as competitive endogenous RNAs (ceRNAs) or small interfering RNAs influencing their parent genes.
03

Disease associations

None documented for HMGN1P20.Other HMGA/HMGN pseudogenes are implicated in cancer progression and possibly in diabetes via gene regulation, but HMGN1P20 is not specifically mentioned in disease.

Beyond the preview

Go deeper on high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call